Biotrend Cevre ve Enerji Yatirimlari A.S. (IST:BIOEN)
Turkey · Delayed Price · Currency is TRY 17.64
-0.28 (-1.56%)
Last updated: Jul 14, 2026, 4:08 PM GMT+3
IST:BIOEN Income Statement
Financials in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,828 | 2,943 | 3,560 | 3,224 | 2,338 | 427.7 | |
Revenue Growth (YoY) | -19.61% | -17.33% | 10.42% | 37.91% | 446.57% | 74.36% |
Operations & Maintenance | 65.12 | 59.66 | 69.48 | 69.5 | 50.97 | 10.27 |
Selling, General & Admin | 628.13 | 642.39 | 623.92 | 456.4 | 249.27 | 42.47 |
Other Operating Expenses | 2,857 | 2,803 | 3,567 | 2,638 | 1,486 | 286.45 |
Total Operating Expenses | 3,550 | 3,505 | 4,260 | 3,164 | 1,787 | 339.19 |
Operating Income | -721.93 | -562.33 | -700.27 | 59.72 | 551.03 | 88.51 |
Interest Expense | -576.32 | -581.95 | -658.32 | -441.46 | -106.86 | -31.55 |
Interest Income | 40.05 | 35.09 | 212.62 | 123.46 | 15.9 | 25.71 |
Net Interest Expense | -536.27 | -546.86 | -445.71 | -318 | -90.96 | -5.84 |
Income (Loss) on Equity Investments | -123.77 | -8.85 | -145.94 | 142.18 | 41.05 | 25.74 |
Currency Exchange Gain (Loss) | -568.87 | -735.08 | -621.57 | 109.91 | -272.02 | -77.32 |
Other Non-Operating Income (Expenses) | 1,445 | 1,140 | 1,756 | 1,361 | 463.03 | -2.46 |
EBT Excluding Unusual Items | -506.2 | -713.1 | -157.3 | 1,355 | 692.13 | 28.64 |
Gain (Loss) on Sale of Investments | -79.97 | -76.55 | -0.03 | -12.15 | - | - |
Insurance Settlements | 13.62 | 13.62 | 41.42 | - | - | - |
Legal Settlements | 4.21 | 4.01 | -1.87 | -2.6 | -6.85 | -5.22 |
Pretax Income | -568.35 | -772.01 | -117.78 | 1,340 | 685.28 | 23.42 |
Income Tax Expense | 292.47 | 610.29 | -30.22 | -31.79 | 108.73 | 19.43 |
Earnings From Continuing Ops. | -860.82 | -1,382 | -87.56 | 1,372 | 576.56 | 4 |
Minority Interest in Earnings | - | - | - | -2.87 | 0.2 | 2.55 |
Net Income | -860.82 | -1,382 | -87.56 | 1,369 | 576.76 | 6.54 |
Net Income to Common | -860.82 | -1,382 | -87.56 | 1,369 | 576.76 | 6.54 |
Net Income Growth | - | - | - | 137.34% | 8716.24% | -87.04% |
Shares Outstanding (Basic) | 500 | 500 | 500 | 500 | 500 | 500 |
Shares Outstanding (Diluted) | 500 | 500 | 500 | 500 | 500 | 500 |
Shares Change (YoY) | - | - | - | - | - | 17.19% |
EPS (Basic) | -1.72 | -2.76 | -0.18 | 2.74 | 1.15 | 0.01 |
EPS (Diluted) | -1.72 | -2.76 | -0.18 | 2.74 | 1.15 | 0.01 |
EPS Growth | - | - | - | 137.34% | 8716.25% | -88.94% |
Free Cash Flow | -61.74 | 153.69 | -2,372 | 100.46 | -354.09 | -767.25 |
Free Cash Flow Per Share | -0.12 | 0.31 | -4.74 | 0.20 | -0.71 | -1.53 |
Profit Margin | -30.44% | -46.97% | -2.46% | 42.46% | 24.67% | 1.53% |
Free Cash Flow Margin | -2.18% | 5.22% | -66.63% | 3.12% | -15.15% | -179.39% |
EBITDA | 87.92 | 213.54 | 48.32 | 617.65 | 831.54 | 119.87 |
EBITDA Margin | 3.11% | 7.26% | 1.36% | 19.16% | 35.57% | 28.03% |
D&A For EBITDA | 809.85 | 775.87 | 748.58 | 557.93 | 280.5 | 31.35 |
EBIT | -721.93 | -562.33 | -700.27 | 59.72 | 551.03 | 88.51 |
EBIT Margin | -25.53% | -19.11% | -19.67% | 1.85% | 23.57% | 20.70% |
Effective Tax Rate | - | - | - | - | 15.87% | 82.94% |